Exelixis, Inc.
EXEL · NASDAQ-GS
| FY2026 | FY2025 | FY2023 | FY2022 | FY2021 | FY2021 | FY2020 | FY2018 | |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $2.32B | $2.17B | $1.83B | $1.61B | $1.43B | $987.54M | $967.77M | $853.83M |
| Cost of Revenue | $83.70M | $76.22M | $72.55M | $57.91M | $52.87M | $36.27M | $33.10M | $26.35M |
| Research & Development | $825.00M | $910.41M | $1.04B | $891.81M | $693.72M | $547.85M | $336.96M | $182.26M |
| Selling, General & Administrative | $518.73M | $492.13M | $542.71M | $459.86M | $401.71M | $293.36M | $228.24M | $206.37M |
| Operating Expenses | $1.45B | $1.56B | $1.66B | $1.41B | $1.15B | $877.48M | $598.30M | $414.97M |
| Operating Income | $872.19M | $604.62M | $170.88M | $201.48M | $286.67M | $110.06M | $369.47M | $438.86M |
| Interest Expense | — | — | — | — | — | — | $0.00 | $0.00 |
| Other Income / (Expense) | -$198.00K | -$133.00K | $93.00K | -$197.00K | -$184.00K | $912.00K | $28.64M | $13.24M |
| Income Before Taxes | — | — | — | — | — | $130.84M | $398.11M | $452.09M |
| Provision for Income Taxes | $158.64M | $160.37M | $49.76M | $52.07M | $63.09M | $19.06M | $77.10M | -$237.98M |
| Net Income | $782.60M | $521.30M | $207.80M | $182.30M | $231.10M | $111.78M | $321.01M | $690.07M |
| Basic EPS | $2.88 | $1.80 | $0.65 | $0.57 | $0.73 | $0.36 | $1.06 | $2.32 |
| Diluted EPS | $2.78 | $1.76 | $0.65 | $0.56 | $0.72 | $0.35 | $1.02 | $2.21 |
| Basic Shares Outstanding | 271.57M | 290.03M | 318.15M | 321.53M | 314.88M | 308.27M | 302.58M | 297.89M |
| Diluted Shares Outstanding | 281.86M | 296.13M | 321.46M | 324.56M | 322.36M | 318.00M | 315.01M | 312.80M |
Analyst Estimates
| Period | Consensus EPS | Low | High | Estimates | Revisions |
|---|---|---|---|---|---|
| Dec 2026 | $3.19 | $3.03 | $3.26 | 5 | ↑0 ↓0 |
| Dec 2027 | $3.71 | $3.31 | $4.38 | 5 | ↑0 ↓1 |
| Dec 2028 | $4.54 | $4.04 | $5.35 | 3 | ↑1 ↓0 |
| Dec 2029 | $6.36 | $6.36 | $6.36 | 1 | ↑0 ↓0 |
